Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
GSK PLC | 0001131399 | Jan-23-2023 | 10 percent owner |
RA Capital Healthcare Fund LP | 0001315082 | Apr-01-2021 | 10 percent owner |
RA CAPITAL MANAGEMENT, L.P. | 0001346824 | Apr-01-2021 | director, 10 percent owner |
Shah Rajeev M. | 0001619841 | Apr-01-2021 | 10 percent owner |
Tan Aik Na | 0001821285 | Aug-18-2020 | director |
Gaiero David G | 0001799784 | Jan-09-2020 | officer: Interim CFO |
CORRIGAN MARK | 0001250661 | Sep-04-2019 | director |
Wagner Heidi L | 0001655029 | Sep-04-2019 | director |
Pott Amy | 0001787363 | Sep-04-2019 | director |
Baldry Mark | 0001644137 | Aug-05-2019 | officer: Chief Commerical Officer |
Kolchinsky Peter | 0001384859 | Aug-10-2017 | director, 10 percent owner |
Rawcliffe Adrian | 0001555851 | Feb-01-2017 | director |
HENRY CHRISTIAN O | 0001263805 | Nov-10-2016 | director |
Regnante Keith | 0001682068 | Aug-16-2016 | officer: Chief Financial Officer |
Panzara Michael A. | 0001679039 | Jul-11-2016 | officer: Franchise Lead, Neurology |
GUERCIOLINI ROBERTO | 0001286837 | Nov-10-2015 | officer: See Remarks |
Verdine Gregory L. | 0001572315 | Nov-10-2015 | director |
Vargeese Chandra | 0001657675 | Nov-10-2015 | officer: See Remarks |
Francis Chris | 0001657709 | Nov-10-2015 | officer: See Remarks |
BOLNO PAUL | 0001657710 | Nov-10-2015 | director, officer: See Remarks |
Moran Kyle | 0001657765 | Nov-10-2015 | officer: See Remarks |
Miura Koji | 0001657766 | Nov-10-2015 | director |
Wada Takeshi | 0001657767 | Nov-10-2015 | director |
TAKANASHI KEN | 0001657768 | Nov-10-2015 | director, 10 percent owner |
Kagoshima Shinsangyo Sousei Investment Limited Partnership | 0001657769 | Nov-10-2015 | 10 percent owner |
Shin Nippon Biomedical Laboratories, Ltd. | 0001657770 | Nov-10-2015 | 10 percent owner |
Tanaka Masaharu | 0001657771 | Nov-10-2015 | director, 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Wave Life Sciences Ltd.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001999371-24-001192 ( Act) Size: 5 KB |
Jan-30-2024 | |
4/A | Document | Amendment to Statement of changes in beneficial ownership of securities Acc-no: 0001104659-24-004581 ( Act) Size: 11 KB |
Jan-17-2024 | |
8-K | Document | Current report filing Acc-no: 0001193125-24-003944 (34 Act) Size: 12570 KB |
Jan-08-2024 | 24518447 |
8-K | Document | Current report filing Acc-no: 0001193125-24-002437 (34 Act) Size: 139 KB |
Jan-04-2024 | 24511860 |
8-K | Document | Current report filing Acc-no: 0001193125-23-296047 (34 Act) Size: 4371 KB |
Dec-15-2023 | 231488895 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0001104659-23-125724 ( Act) Size: 10 KB |
Dec-13-2023 | |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-23-291137 (33 Act) Size: 1065 KB |
Dec-08-2023 | 231473862 |
8-K | Document | Current report filing Acc-no: 0001193125-23-290972 (34 Act) Size: 562 KB |
Dec-08-2023 | 231473806 |
424B5 | Document | Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001193125-23-289905 (33 Act) Size: 1099 KB |
Dec-06-2023 | 231469733 |
8-K | Document | Current report filing Acc-no: 0001193125-23-274537 (34 Act) Size: 5535 KB |
Nov-09-2023 | 231392984 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-23-274107 (33 Act) Size: 130 KB |
Nov-09-2023 | 231390259 |
S-8 | Document | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0001193125-23-274106 (33 Act) Size: 128 KB |
Nov-09-2023 | 231390257 |
10-Q | Document | Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-23-061544 (34 Act) Size: 6028 KB |
Nov-09-2023 | 231390119 |
8-K | Document | Current report filing Acc-no: 0001193125-23-274068 (34 Act) Size: 271 KB |
Nov-09-2023 | 231390096 |
8-K | Document | Current report filing Acc-no: 0001193125-23-248077 (34 Act) Size: 16967 KB |
Oct-02-2023 | 231297731 |
8-K | Document | Current report filing Acc-no: 0001193125-23-245724 (34 Act) Size: 189 KB |
Sep-28-2023 | 231290343 |
8-K | Document | Current report filing Acc-no: 0001193125-23-228527 (34 Act) Size: 10069 KB |
Sep-05-2023 | 231235740 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-23-018361 ( Act) Size: 5 KB |
Aug-23-2023 | |
144 | Document | Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-23-003409 (33 Act) Size: 7 KB |
Aug-23-2023 | 231198163 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-23-017916 ( Act) Size: 5 KB |
Aug-09-2023 |
Recent 20 filings. View all Wave Life Sciences Ltd. filings
Very good communication and delivery made within the timeframe I was advised of
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by